Literatur
-
1 Rieckmann P, Toyka K V. Leitlinie Diagnostik und Therapie der Multiplen Sklerose. Herausgegeben von der Kommission der Deutschen Gesellschaft für Neurologie (DGN), der Deutschen Multiple Sklerose Gesellschaft (DMSG) und der Multiple Sklerose Therapie Konsensusgruppe (MSTKG). In: Diener HC (ed). Leitlinien für Diagnostik und Therapie in der Neurologie. Stuttgart, New York: Thieme 2005
-
2
Multiple Sklerose Therapie Konsensusgruppe (MSTKG) .
Immunmodulatorische Stufentherapie der multiplen Sklerose. Aktuelle Therapieempfehlung (September 2006).
Nervenarzt.
2006;
77
1506-1518
-
3
Multiple Sklerose Therapie Konsensusgruppe (MSTKG) .
Immunmodulatorische Stufentherapie der Multiplen Sklerose. Neue Aspekte und praktische Umsetzung, März 2002.
Nervenarzt.
2002;
73
556-563
-
4
Rieckmann P, Toyka K V, Bassetti C. et al .
Escalating immunotherapy of multiple sclerosis-new aspects and practical application.
J Neurol.
2004;
251
1329-1339
-
5
Pugliatti M, Rosati G, Carton H. et al .
The epidemiology of multiple sclerosis in Europe.
Eur J Neurol.
2006;
13
700-722
-
6
Hemmer B, Archelos J J, Hartung H P.
New concepts in the immunopathogenesis of multiple sclerosis.
Nat Rev Neurosci.
2002;
3
291-301
-
7
Lucchinetti C, Bruck W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H.
Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination.
Ann Neurol.
2000;
47
707-717
-
8
Confavreux C, Vukusic S, Moreau T, Adeleine P.
Relapses and progression of disability in multiple sclerosis.
N Engl J Med.
2000;
343
1430-1438
-
9
Ramsaransing G S, De Keyser J.
Benign course in multiple sclerosis: a review.
Acta Neurol Scand.
2006;
113
359-369
-
10
Miller D, Barkhof F, Montalban X, Thompson A, Filippi M.
Clinically isolated syndromes suggestive of multiple sclerosis, part I: natural history, pathogenesis, diagnosis, and prognosis.
Lancet Neurol.
2005;
4
281-288
-
11
Tintore M, Rovira A, Rio J. et al .
Baseline MRI predicts future attacks and disability in clinically isolated syndromes.
Neurology.
2006;
67
968-972
-
12
Kallmann B A, Fackelmann S, Toyka K V, Rieckmann P, Reiners K.
Early abnormalities of evoked potentials and future disability in patients with multiple sclerosis.
Mult Scler.
2006;
12
58-65
-
13
Confavreux C, Vukusic S, Adeleine P.
Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process.
Brain.
2003;
126
770-782
-
14
Brex P A, Ciccarelli O, O'Riordan J I, Sailer M, Thompson A J, Miller D H.
A longitudinal study of abnormalities on MRI and disability from multiple sclerosis.
N Engl J Med.
2002;
346
158-164
-
15
Barkhof F, Filippi M, Miller D H. et al .
Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis.
Brain.
1997;
120 (Pt 11)
2059-2069
-
16
Tintore M, Rovira A, Martinez M J. et al .
Isolated demyelinating syndromes: comparison of different MR imaging criteria to predict conversion to clinically definite multiple sclerosis.
AJNR Am J Neuroradiol.
2000;
21
702-706
-
17
Polman C H, Reingold S C, Edan G, Filippi M, Hartung H P, Kappos L. et al .
Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”.
Ann Neurol.
2005;
58
840-846
-
18
Simon J H, Li D, Traboulsee A. et al .
Standardized MR imaging protocol for multiple sclerosis: Consortium of MS Centers consensus guidelines.
AJNR Am J Neuroradiol.
2006;
27
455-461
-
19
Link H, Huang Y M.
Oligoclonal bands in multiple sclerosis cerebrospinal fluid: An update on methodology and clinical usefulness.
J Neuroimmunol.
2006;
180
17-28
-
20 Zettl U K, Tumani H. Multiple Sklerose und Liquordiagnostik. Oxford: Blackwell 2006: 1-123
-
21
McDonald W I, Compston A, Edan G. et al .
Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis.
Ann Neurol.
2001;
50
121-127
-
22
Stangel M, Gold R, Gass A. et al .
Current issues in immunomodulatory treatment of multiple sclerosis-a practical approach.
J Neurol.
2006;
253 (pt 1)
I32-36
Priv.-Doz. Dr. med. Andreas Steinbrecher
Neurologische Universitätsklinik Regensburg
Universitätsstraße 84
93053 Regensburg
Email: andreas.steinbrecher@medbo.de
